These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24996134)

  • 1. Bioengineering 3D environments for cancer models.
    Alemany-Ribes M; Semino CE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():40-9. PubMed ID: 24996134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-engineered three-dimensional tumor models to study tumor angiogenesis.
    Verbridge SS; Chandler EM; Fischbach C
    Tissue Eng Part A; 2010 Jul; 16(7):2147-52. PubMed ID: 20214471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro three-dimensional (3D) models in cancer research: an update.
    Kimlin LC; Casagrande G; Virador VM
    Mol Carcinog; 2013 Mar; 52(3):167-82. PubMed ID: 22162252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concepts of metastasis in flux: the stromal progression model.
    Sleeman JP; Christofori G; Fodde R; Collard JG; Berx G; Decraene C; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):174-86. PubMed ID: 22374376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioengineered 3D Scaffolds in Cancer Research: Focus on Epithelial to Mesenchymal Transition and Drug Screening.
    Xu X; Tang L
    Curr Pharm Des; 2017; 23(11):1710-1720. PubMed ID: 27908265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
    Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
    Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Co-option a prevailing mechanism during cancer progression?
    Billaud M; Santoro M
    Cancer Res; 2011 Nov; 71(21):6572-5. PubMed ID: 22028321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-mesenchymal transition in morphogenesis, cancer progression and angiogenesis.
    Ribatti D
    Exp Cell Res; 2017 Apr; 353(1):1-5. PubMed ID: 28257786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Encounter of cancer cells with bone. The significance of cancer stem cells and epithelial-mesenchymal transition in tumor invasion and metastasis].
    Yoshida GJ; Saya H
    Clin Calcium; 2011 Mar; 21(3):411-7. PubMed ID: 21358063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineering approaches to guide stem cell-based organogenesis.
    Gjorevski N; Ranga A; Lutolf MP
    Development; 2014 May; 141(9):1794-804. PubMed ID: 24757002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Encounter of cancer cells with bone. Epithelial-mesenchymal transition in cancer].
    Horiguchi K; Saitoh M
    Clin Calcium; 2011 Mar; 21(3):405-10. PubMed ID: 21358062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.
    Ginnebaugh KR; Ahmad A; Sarkar FH
    Expert Opin Ther Targets; 2014 Jul; 18(7):731-45. PubMed ID: 24758643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translating cancer research by synthetic biology.
    Shankar S; Pillai MR
    Mol Biosyst; 2011 Jun; 7(6):1802-10. PubMed ID: 21437339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering tumors: a tissue engineering perspective in cancer biology.
    Burdett E; Kasper FK; Mikos AG; Ludwig JA
    Tissue Eng Part B Rev; 2010 Jun; 16(3):351-9. PubMed ID: 20092396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studying the influence of angiogenesis in in vitro cancer model systems.
    Roudsari LC; West JL
    Adv Drug Deliv Rev; 2016 Feb; 97():250-9. PubMed ID: 26571106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses.
    Loessner D; Holzapfel BM; Clements JA
    Adv Drug Deliv Rev; 2014 Dec; 79-80():193-213. PubMed ID: 24969478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The function of the RNA-binding protein hnRNP in cancer metastasis.
    Han N; Li W; Zhang M
    J Cancer Res Ther; 2013 Nov; 9 Suppl():S129-34. PubMed ID: 24516048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can tissue engineering concepts advance tumor biology research?
    Hutmacher DW; Loessner D; Rizzi S; Kaplan DL; Mooney DJ; Clements JA
    Trends Biotechnol; 2010 Mar; 28(3):125-33. PubMed ID: 20056286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.